Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LCMC URGENT CARE LLC

NPI: 1184162877 · NEW ORLEANS, LA 70124 · Urgent Care Clinic/Center · NPI assigned 02/02/2017

$9.72M
Total Medicaid Paid
232,138
Total Claims
189,092
Beneficiaries
39
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSAMSON, TAMARA (PRESIDENT)
NPI Enumeration Date02/02/2017

Related Entities

Other providers sharing the same authorized official: SAMSON, TAMARA

ProviderCityStateTotal Paid
TRINITY HEALTH OF NEW ENGLAND URGENT CARE PLLC BLOOMFIELD CT $3.93M
MERCY HEALTH URGENT CARE GRAND RAPIDS MI $2.64M
MERCYONE URGENTCARE CLINTON IA $1.28M
MERCYONE CENTRAL IOWA URGENT CARE DES MOINES IA $1.13M
HOLY CROSS URGENT CARE FORT LAUDERDALE FL $2K
FAMILY FIRST EXPRESS CARE PLLC LEANDER TX $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,939 $283K
2019 18,962 $871K
2020 24,580 $1.11M
2021 40,097 $1.90M
2022 57,382 $2.29M
2023 47,598 $1.86M
2024 38,580 $1.41M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 41,441 37,355 $3.25M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 33,785 30,060 $2.41M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 19,895 18,198 $1.60M
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 16,759 15,496 $1.49M
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 26,140 20,357 $382K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6,655 5,511 $166K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 27,745 11,677 $120K
S9088 Services provided in an urgent care center (list in addition to code for service) 13,793 12,325 $57K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 963 832 $49K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 564 522 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13,137 10,745 $40K
99051 7,511 6,312 $35K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,323 1,652 $30K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6,026 4,932 $22K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 685 581 $9K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 98 83 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 7,233 6,257 $3K
81003 3,999 3,210 $2K
99215 Prolong outpt/office vis 16 15 $2K
81025 431 389 $788.75
87807 214 181 $383.66
J0696 Injection, ceftriaxone sodium, per 250 mg 385 308 $148.04
73630 13 13 $110.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 16 14 $70.00
99000 508 451 $15.00
J1885 Injection, ketorolac tromethamine, per 15 mg 608 468 $1.85
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 27 25 $1.75
3008F 251 245 $0.00
3079F 28 28 $0.00
A9150 Non-prescription drugs 197 176 $0.00
3074F 148 144 $0.00
3080F 12 12 $0.00
82962 15 15 $0.00
1160F 310 304 $0.00
3077F 17 17 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 14 14 $0.00
3078F 97 94 $0.00
J7510 Prednisolone oral, per 5 mg 66 61 $0.00
71046 Radiologic examination, chest; 2 views 13 13 $0.00